101 related articles for article (PubMed ID: 26462515)
41. Aberrant promoter methylation and silencing of the POU2F3 gene in cervical cancer.
Zhang Z; Huettner PC; Nguyen L; Bidder M; Funk MC; Li J; Rader JS
Oncogene; 2006 Aug; 25(39):5436-45. PubMed ID: 16607278
[TBL] [Abstract][Full Text] [Related]
42. Molecular biology of cervical cancer and its precursors.
Heilmann V; Kreienberg R
Curr Womens Health Rep; 2002 Feb; 2(1):27-33. PubMed ID: 12112980
[TBL] [Abstract][Full Text] [Related]
43. Sphingosine kinase 1 is a reliable prognostic factor and a novel therapeutic target for uterine cervical cancer.
Kim HS; Yoon G; Ryu JY; Cho YJ; Choi JJ; Lee YY; Kim TJ; Choi CH; Song SY; Kim BG; Bae DS; Lee JW
Oncotarget; 2015 Sep; 6(29):26746-56. PubMed ID: 26311741
[TBL] [Abstract][Full Text] [Related]
44. Over-expression of FOXM1 transcription factor is associated with cervical cancer progression and pathogenesis.
Chan DW; Yu SY; Chiu PM; Yao KM; Liu VW; Cheung AN; Ngan HY
J Pathol; 2008 Jul; 215(3):245-52. PubMed ID: 18464245
[TBL] [Abstract][Full Text] [Related]
45. Systematic identification of key genes and pathways in the development of invasive cervical cancer.
Niu G; Wang D; Pei Y; Sun L
Gene; 2017 Jun; 618():28-41. PubMed ID: 28341182
[TBL] [Abstract][Full Text] [Related]
46. MicroRNAs are involved in cervical cancer development, progression, clinical outcome and improvement treatment response (Review).
González-Quintana V; Palma-Berré L; Campos-Parra AD; López-Urrutia E; Peralta-Zaragoza O; Vazquez-Romo R; Pérez-Plasencia C
Oncol Rep; 2016 Jan; 35(1):3-12. PubMed ID: 26530778
[TBL] [Abstract][Full Text] [Related]
47. Homeobox C5 expression is associated with the progression of 4-nitroquinoline 1-oxide-induced rat tongue carcinogenesis.
Moon SM; Ahn MY; Kwon SM; Kim SA; Ahn SG; Yoon JH
J Oral Pathol Med; 2012 Jul; 41(6):470-6. PubMed ID: 22385119
[TBL] [Abstract][Full Text] [Related]
48. MiR-205 serves as a prognostic factor and suppresses proliferation and invasion by targeting insulin-like growth factor receptor 1 in human cervical cancer.
Pang H; Yue X
Tumour Biol; 2017 Jun; 39(6):1010428317701308. PubMed ID: 28651495
[TBL] [Abstract][Full Text] [Related]
49. [Wnt signalling pathway and cervical cancer].
Ramos-Solano M; Álvarez-Zavala M; García-Castro B; Jave-Suárez LF; Aguilar-Lemarroy A
Rev Med Inst Mex Seguro Soc; 2015; 53 Suppl 2():S218-24. PubMed ID: 26462520
[TBL] [Abstract][Full Text] [Related]
50. Differential expression of HOX genes in neoplastic and non-neoplastic human astrocytes.
Abdel-Fattah R; Xiao A; Bomgardner D; Pease CS; Lopes MB; Hussaini IM
J Pathol; 2006 May; 209(1):15-24. PubMed ID: 16463268
[TBL] [Abstract][Full Text] [Related]
51. Aberrant DNA methylation of DLX4 and SIM1 is a predictive marker for disease progression of uterine cervical low-grade squamous intraepithelial lesion.
Sakane J; Taniyama K; Miyamoto K; Saito A; Kuraoka K; Nishimura T; Sentani K; Oue N; Yasui W
Diagn Cytopathol; 2015 Jun; 43(6):462-70. PubMed ID: 25614457
[TBL] [Abstract][Full Text] [Related]
52. Down-regulation of insulin-like growth factor binding protein-5 (IGFBP-5): novel marker for cervical carcinogenesis.
Miyatake T; Ueda Y; Nakashima R; Yoshino K; Kimura T; Murata T; Nomura T; Fujita M; Buzard GS; Enomoto T
Int J Cancer; 2007 May; 120(10):2068-77. PubMed ID: 17290407
[TBL] [Abstract][Full Text] [Related]
53. MicroRNA-145 inhibits tumorigenesis and invasion of cervical cancer stem cells.
Zhou X; Yue Y; Wang R; Gong B; Duan Z
Int J Oncol; 2017 Mar; 50(3):853-862. PubMed ID: 28112371
[TBL] [Abstract][Full Text] [Related]
54. Molecular implications of HOX genes targeting multiple signaling pathways in cancer.
Shenoy US; Adiga D; Kabekkodu SP; Hunter KD; Radhakrishnan R
Cell Biol Toxicol; 2022 Feb; 38(1):1-30. PubMed ID: 34617205
[TBL] [Abstract][Full Text] [Related]
55. Role of Oct3/4 in Cervical Cancer Tumorigenesis.
Clemente-Periván SI; Gómez-Gómez Y; Leyva-Vázquez MA; Lagunas-Martínez A; Organista-Nava J; Illades-Aguiar B
Front Oncol; 2020; 10():247. PubMed ID: 32219062
[TBL] [Abstract][Full Text] [Related]
56. Potential role of exitron-containing homeobox genes in cancer.
de Faria Poloni J; Feltes BC
WIREs Mech Dis; 2023; 15(3):e1606. PubMed ID: 36974895
[TBL] [Abstract][Full Text] [Related]
57. Heterotopic expression of homeobox genes as a cause of organ specific metastasis.
Chigira M; Shinozaki T; Watanabe H
Med Hypotheses; 1994 Mar; 42(3):211-3. PubMed ID: 7914666
[TBL] [Abstract][Full Text] [Related]
58. Novel mutations in cervical cancer.
Burki TK
Lancet Oncol; 2017 Mar; 18(3):e137. PubMed ID: 28163002
[No Abstract] [Full Text] [Related]
59. Homeobox genes: molecular link between congenital anomalies and cancer.
Anbazhagan R; Raman V
Eur J Cancer; 1997 Apr; 33(4):635-7. PubMed ID: 9274447
[TBL] [Abstract][Full Text] [Related]
60. Role of HOXA1-4 in the development of genetic and malignant diseases.
Wang L; Sun H; Cao L; Wang J
Biomark Res; 2024 Feb; 12(1):18. PubMed ID: 38311789
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
